article thumbnail

Mechoulam on the Future of Cannabinoid Research

Project CBD

I was fortunate to cross paths with Raphael Mechoulam, “the father of cannabis research,” at several science conferences over the years. The most memorable occasion was the 22nd annual meeting of the International Cannabinoid Research Society (ICRS) in Freiburg, Germany, in July 2012.

article thumbnail

Cannabis as a cancer cure: what is the research and where is it going?

The Cannigma

Before we dive into the research, here’s the lowdown: Important takeaway points on cannabis and cancer Your situation is unique. Advocate for the rescheduling of cannabis to improve access to cannabis for research purposes, and scientific funding for novel cannabinoid-based cancer therapies. 1 So can cannabis cure cancer?

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

The Top Medical Cannabis Research of 2017

MGC Pharma

The Top Medical Cannabis Research of 2017 A word from Ron Lipsky, Manager of Business Development and International Relations at MGC Pharmaceuticals MGC Pharma is still riding off the success of 2017 as we progress into 2018, with many exciting developments on the horizon.

article thumbnail

CBD Science Update

Project CBD

The 29th annual International Cannabinoid Research Society ( ICRS ) symposium, which convened last month in Bethesda, Maryland, featured new developments in CBD science that have far-reaching implications for many areas of medicine. But would tolerance develop with repeated dosing, thereby mitigating CBD ’s hypotensive effect?

CBD 222
article thumbnail

Here’s what you need to know about cannabis research

The Cannigma

There’s no doubt that the amount of information that is available about cannabis is at an all-time high – in 2020 alone, over 3,500 scientific articles were published on the topic. Research funding is also up, and all of this data influences how we see, think and hear about the plant and its effects.

article thumbnail

The National Institute on Drug Abuse (NIDA) Funding Research On Differing Legal Cannabis Regulatory Models

Cannabis Law Report

The National Institute on Drug Abuse (NIDA) is renewing its push to promote federally funded research into marijuana as more states enact reform—specifically expressing interest in studies on differing cannabis regulatory models that are in place across the country. Read full report.

article thumbnail

Dyskinesia Drugs In Development Pipeline Report 2021 – ResearchAndMarkets.com

Cannabis Law Report

DUBLIN–(BUSINESS WIRE)–The “Dyskinesia (Central Nervous System) – Drugs In Development, 2021” report has been added to ResearchAndMarkets.com’s offering. Dyskinesia – Drugs In Development, 2021, provides an overview of the Dyskinesia (Central Nervous System) pipeline landscape. Appendix.